FDA adopts simulation tech

The FDA will deploy new computer technology from Entelos to simulate the activity of experimental medications so the agency can get an earlier read on the safety and efficacy of drugs in the pipeline. The Wall Street Journal reports that the FDA will announce the pact later today, highlighting how new computer simulations can be used to guide developers in the design of clinical trials. At a later point, the agency may also use the information it gleans to help define prescribing guidelines. Report